[ET Net News Agency, 27 February 2026] SINO BIOPHARM (01177) fell 3.4% to HK$5.94.
It hits an intra-day low of HK$5.93, hitting an 1-month low, dipping below the 250-D SMA of HK$6.031, and an intra-day high of HK$6.15. The total shares traded was 16.02 million, with a value of HK$96.16m. The active buy/sell ratio is 54:46, with net buying turnover of HK$7.25m. CHINA INNOVATION MARKET SER accounts for greatest net responsive buying turnover of HK$3.98m, with volume weighted average price of HK$5.994. MORGAN STANLEY HK SEC accounts for greatest net responsive selling turnover of HK$11.73m, with volume weighted average price of HK$5.994. The stock has fallen a combined 7% over the past 2 consecutive trading days.
The Hang Seng Index now rose 75 points, or 0.3% to 26,456.
Basic Information| Nominal | 5.940 | % Chg | -3.41% |
| High | 6.150 | Low | 5.930 |
| Shares Tr | 16.02m | Turnover | 96.16m |
| 10-D SMA | 6.481 | %H.V | 44.355 |
| 20-D SMA | 6.524 | VWAP | 6.002 |
| 50-D SMA | 6.570 | RSI14 | 34.391 |
Status: Dipping below the 250-D SMA, hitting an 1-month low, active buy/sell ratio is 54:46, with net buying turnover of HK$7.25m, falling a combined 7% over the past 2 consecutive trading days
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| SINO BIOPHARM (01177) | 5.94 | -3.41 |
| SIHUAN PHARM (00460) | 1.56 | +0.65 |
| GRAND PHARMA (00512) | 7.81 | +0.77 |
| HENGRUI PHARMA (01276) | 66.70 | +1.06 |
| LIVZON PHARMA (01513) | 29.08 | +0.34 |
| LUYE PHARMA (02186) | 2.59 | Unchanged |
| FOSUN PHARMA (02196) | 19.99 | +0.91 |
| SH PHARMA (02607) | 11.70 | +0.34 |
| CHINARES PHARMA (03320) | 4.57 | -0.65 |
| HANSOH PHARMA (03692) | 34.48 | +0.82 |
(ed)
